Ryan I. Nasseri, MD, BS

Disclosure information not submitted.

Presentation(s):

• MP24-11: Is Pathological Upstaging to T3 Renal Cell Carcinoma Associated with a Similar Prognosis to Non-Upstaged Pathologic T3 Disease? A Multicenter Analysis

  Saturday, May 14, 2022
  8:45 AM – 10:00 AM

• MP24-13: Impact of Primary Tumor Size on Cancer-Specific and All-Cause Mortality in Patients Undergoing Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma: Analysis from the INternational Marker Consortium for Renal Cancer [INMARC]

  Saturday, May 14, 2022
  8:45 AM – 10:00 AM

• V13-06: Open Right Partial Nephrectomy with Inferior Vena Cava Thrombectomy for Renal Cell Carcinoma

  Monday, May 16, 2022
  1:50 PM – 2:00 PM